Cornelia de Lange syndrome is a congenital syndrome of unknown origin diagnosed on the basis of facial characteristics consisting of synophrys (eyebrows joined at the midline), long eyelashes, long philtrum (area between the upper nose and the lip), thin upper lip, and a downturned mouth. It is a multisystemic disease that most often affects the gastrointestinal tract and the heart. Patients also present with mental retardation as well as many skeletal system malformations. It is estimated that this syndrome affects one in 10,000 newborns.
This syndrome was named after the physician who described the condition in Amsterdam in 1933. It is also known as Amsterdam Dwarf Syndrome of de Lange. In 1916, another physician named Brachmann first described a more severe form of this syndrome and therefore it is also known as Brachmann-de Lange syndrome. As of 2001, it is known that there are three distinct categories of this condition.
The most severe form of this condition is the Type I or "classic form". Patients with this form have a prenatal growth deficiency that is noticeable after birth. In addition, these patients are marked with a distinct face and moderate to profound mental retardation. These individuals often have major deformities in the gastrointestinal tract and heart which may lead to severe incapacity or death.
The mild form of this condition is known as the Type II form. This is characterized by similar facial features to that of Type I, however, they may not become apparent until later in life. Along with a less severe pre- and post-natal growth deficiency, major malformations are seen at a decreased rate or may be absent completely.
Type III Cornelia de Lange syndrome, also called phenocopy, includes patients who have phenotypic manifestations of the syndrome that are related to chromosomal aneuplodies or teratogenic factors.
The syndrome is suspected to be genetic in origin but the mode of transmission is unknown. Most cases are sporadic and are thought to result from a new mutation (an abnormal sequence of the components that make a gene). There is also evidence that this may be transmitted in an autosomal dominant fashion, thus if only one parent is affected there exists a 50% chance of transmitting the abnormal gene to each child. A gene of chromosome 3 may be responsible for the syndrome.
Cornelia de Lange syndrome appears to affect males and females in equal numbers. It is more common to see
A number of gastrointestinal (GI) problems can manifest and are by far the most common system involved. Both the upper and lower GI tract can be involved.
Heart problems are not uncommon in patients with Cornelia de Lange syndrome.
Most people afflicted with Cornelia de Lange syndrome have both prenatal and postnatal growth deficiencies as well as a developmental delay. This may be due to endocrine system involvement concerning a growth hormone delivery problem. Most patients have a characteristically short stature, but often have a pubertal growth spurt at a comparable age to normal individuals.
Developmental delays are numerous and are found in most patients with Cornelia de Lange syndrome. Some of the delays include walking alone, speaking, toilet training, and dressing. In some instances these patients never reach these milestones. Other developmental delays include IQ, which is within the mild to moderate range for mental retardation and averages 53.
Many patients with Cornelia de Lange syndrome often have some form of hearing loss. Cases may range from mild to severe, and may affect either one or both ears. This loss can be attributed to a lack of prenatal development of some of the important bony structures associated with the inner ear. In addition, development failure of important neural elements play a role in this hearing loss.
A significant number of Cornelia de Lange syndrome patients have eye and/or vision problems including:
Other malformations include undescended testicles, which can cause fertility problems. Diaphragmatic hernia is another complication that may lead to GI difficulties. Patients may also have a cleft palate and a low-pitched growl or cry.
Cornelia de Lange syndrome has no set criteria that can indicate with absolute certainty whether or not a child is afflicted. This is due in part to a lack of specific biochemical markers postnatally that would lead a clinician to a definitive diagnosis. However, diagnosis is made subjectively from the characteristic symptoms that are present in this condition including the ones listed above. Perhaps the most diagnostic tool is the distinguishing face that a patient has, combined with facial hypertrichosis.
Prenatal diagnosis is possible through the use of ultrasound. The association of intrauterine growth retardation, oligodactyly, an absent ulna, underdevelopment of hands, diaphragmatic hernia, and cardiac defects lead to the differential diagnosis. When uncertain, the presence of long eyelashes or unusually long hair on the back restrict the diagnosis to Cornelia de Lange syndrome.
Researchers have also found that maternal serum samples collected from women who gave birth to a child with Cornelia de Lange syndrome revealed low levels of a pregnancy associated plasma protein-A (PAPP-A) during the second trimester. In addition, it has been noted that an amniotic molecule (5-OH-indole-3-acetic acid), and a fetal serum protein (galactose-1-phosphate-uridyltrasferase) were increased in afflicted individuals.
The treatment and management of patients with Cornelia de Lange syndrome is strictly symptomatic.
For patients with limb and digit malformations a variety of prosthesis are advised if necessary. Physical and occupational therapy may also be needed. Surgery may be necessary to correct more severe deformities.
Gastroesophageal reflux disease (GERD) can be treated with special diets and a number of different drugs that either block acid secretion from the stomach or neutralize acid once it is produced. Drugs may include antacids, histamine receptor blockers, and proton pump inhibitors. If these treatments prove unsuccessful, surgery my be performed to eliminate the possibility of further complications such as Barrett's esophagus or esophageal stenosis.
Patients with Cornelia de Lange syndrome should have endoscopic evaluation with biopsies for Barrett's esophagus. If this occurs, treatment will include the aforementioned drugs to reduce stomach acid and removal of the precancerous tissue may be indicated. Surgery to shorten the esophagus may also be performed.
Esophageal stenosis treatment may include a procedure done in order to dilate the esophagus. Some patients may require surgery to implant a stent or to replace part of the esophagus.
Gastric ulcers are often treated by the same means used to treat GERD. In addition, antibiotics are used in order to eliminate any bacteria that may be the cause of the ulcer. Sucralfate may be used to form a barrier over the ulcer that protects it from stomach acid allowing it to heal.
Patients with pyloric stenosis normally require surgery in order to widen the canal leading from the stomach to the duodenum. In addition, those with intestinal malrotation may require surgery depending on the severity of the condition. Surgery may also be required for patients with Meckel diverticulum if bleeding is a problem.
In mild cases of cardiovascular involvement, no treatment plan is initiated other than to monitor the dysfunctions. Some of the septal defects may be asymptomatic and heal on their own. Since most of these abnormalities can lead to infective endocarditis, patients should be given antibiotics before undergoing dental procedures or surgeries. Most often penicillin or amoxicillin are used.
For patients who develop congestive heart failure, a regiment of drugs known as beta blockers may be useful to slow down the heart. Other drugs that may be used are diuretics to prevent fluid retention or ACE inhibitors.
For more serious cardiac involvement surgery is recommended. Surgery for tetralogy of Fallot involves widening the pulmonary valve and repairing the ventricular septal defect. This surgery is normally performed on patients between the ages of eight months and three years. Ventricular septal defects can be repaired usually with a synthetic patch. Atrial septal defects are normally performed by catherization by placing a device between the atria in the septum. Patent ductus arteriosus correction is done by either ligating the vessel or cutting it off.
Patients diagnosed with Cornelia de Lange syndrome should be examined for hearing loss as soon as possible due to the possibility of speech delay that may
It is also important to identify vision problems early. Glasses may be necessary for nearsightedness. Children should be seen by an opthamologist in order to assess limitations and to develop a treatment plan.
Since development of speech is often delayed, people affected with Cornelia de Lange syndrome should be seen by a speech pathologist at an early age. Alternative communication strategies, such as sign language, may be employed depending on the level of speech development.
Children and family members may also benefit from therapy available from a number of organizations. Patients may qualify for health related support services from a variety of national support services for retarded persons.
Patients with Cornelia de Lange syndrome can live well into adulthood, however, it is typical for most to have a shortened lifespan. In 1976, a nationwide survey in Denmark revealed the oldest patient was found to be 49 years old.
A patient's prognosis can be improved by early diagnosis and intervention. These two factors can influence not only the patients life expectancy, but also their quality of life and those lives of the family and caregivers.
Behrman, Richard, ed. "Intestinal Atresia, Stenosis, and Malrotation." In Nelson Textbook of Pediatrics. 16th ed. Philadelphia: W.B Saunders Company, 2000.
Oski, Frank A., ed. "Cornelia de Lange's Syndrome." In Principles and Practice of Pediatrics. 2nd ed. Philadelphia: Lippincott, 1994.
Thoene, Jess G., ed. "Cornelia de Lange Syndrome." In Physicians' Guide to Rare Diseases. 2nd ed. Montvale, N.J.: Dowden Publishing Company, 1995.
Aitken, D.A., et al. "Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange Syndrome pregnancies." Prenatal Diagnosis 19 (1999): 706–10.
Akhtar, M.I., et al. "Cornelia de Lange Syndrome and Barrett's Esophagus:123." Journal of Pediatric Gastro and Nutrition 25 (1997): 473.
Boog, G., et al. "Brachmann-de Lange syndrome: a cause of early symmetric fetal growth delay." European Journal of Obstetrics & Gynecology and Reproductive Biology 85 (1999): 173–77.
Jackson, L., et al. "de Lange Syndrome: a clinical review of 310 individuals." American Journal of Medical Genetics 47 (1993): 940–46.
Kimitaka, K., et al. "Auditory brainstem responses in children with Cornelia de Lange Syndrome." International Journal of Pediatric Otorhinolaryngology 31 (1995): 137–46.
Kline, A.D., et al. "Developmental data on individuals with the Brachmann-de Lange syndrome." American Journal of Medical Genetics 47 (1993): 1053–58.
Kousseff, B.G., et al. "Physical growth in Brachmann-de Lange Syndrome." American Journal of Medical Genetics 47 (1993): 1050–52.
Mehta, A.V., et al. "Occurrence of congenital heart disease in children with Brachmann-de Lange Syndrome." American Journal of Medical Genetics 71 (1997): 434–35.
Sasaki, T., et al. "Temporal bone and brain stem histopathological findings in Cornelia de Lange syndrome." International Journal of Pediatric Otorhinolaryngology 36 (1996): 195–204.
Scaillon, M., et al. "Oesophageal motility disorders in Cornelia de Lange Syndrome original feature or oesophagitis related abnormalities?" Journal of Pediatric Gastro and Nutrition. 25, supplement 1 (1997): 46.
Alliance of Genetic Support Groups. 4301 Connecticut Ave. NW, Suite 404, Washington, DC 20008. (202) 966-5557. Fax: (202) 966-8553. <http://www.geneticalliance.org>.
Cornelia de Lange Syndrome Foundation, Inc. 302 West Main St., Suite 100, Avon, CT 06001. (860) 676-8166 (800) 223-8355. Fax: (860) 676-8337.
March of Dimes Birth Defects Foundation. 1275 Mamaroneck Ave., White Plains, NY 10605. (888) 663-4637. resourcecenter@modimes.org. <http://www.modimes.org>.
National Organization for Rare Disorders (NORD). PO Box 8923, New Fairfield, CT 06812-8923. (203) 746-6518 or (800) 999-6673. Fax: (203) 746-6481. <http://www.rarediseases.org>.
Cornelia de Lange Syndrome USA Foundation. <http://www.Cornelia de Lange Syndromeoutreach.org>.
MD Consult. <http://www.mdconsult.com>.
Medscape. <http://www.medscape.com>.
NORD—National Organization for Rare Disorders Inc. <http://www.rarediseases.org/>.
OMIM—Online Mendelian Inheritance in Man. National Center for Biotechnology Information. <http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=&db=OMIM&term=>.
WebMD. <http://www.webmd.com>.
Laith F. Gulli, MD and Robert Ramirez, BS